| Wheaton Franciscan Hospice 3070 N 51st St Suite 406, Milwaukee, WI, 53210 | |
| (414) 874-6170 |
News Archive
Paratek Pharmaceuticals, Inc. announced today that it has entered into an exclusive worldwide collaborative development, manufacturing and commercialization license agreement with Novartis for Paratek's lead broad-spectrum antibiotic, PTK 0796, a first-in-class aminomethylcycline (AMC) in Phase 3 clinical trials.
meeting with healthcare leaders to discuss ways to improve their financial performance and enhance the patient experience while exhibiting at the Healthcare Financial Management Association's Annual National Institute June 16-19 in Orlando, FL.
In the current issue of Psychotherapy and Psychosomatics a randomized controlled trial indicates that group therapy may affect the course of bipolar disorder. This study evaluated the effectiveness of adjunctive cognitive behavioral group therapy to prevent recurrence of episodes in 50 euthymic patients with bipolar disorder types I and II followed up for at least 12 months in an outpatient service and whose disease was in remission.
Virttu Biologics Limited, a UK biotechnology company with expertise in the field of oncolytic viruses, has announced that it has treated the first cohort of patients in its Phase I/IIa clinical study of its oncolytic virus, SEPREHVIR (HSV1716) for the treatment of malignant pleural mesothelioma.
› Verified 4 days ago
| Name | Wheaton Franciscan Hospice |
|---|---|
| Location | 3070 N 51st St Suite 406, Milwaukee, Wisconsin |
| Hospice ID | 521561 |
| Category | Part of a Home Health Agency |
| Ownership Type | Voluntary Non-profit - Private |
| Profit Type | NON-PROFIT |
| SSA county code | 390 |
News Archive
Paratek Pharmaceuticals, Inc. announced today that it has entered into an exclusive worldwide collaborative development, manufacturing and commercialization license agreement with Novartis for Paratek's lead broad-spectrum antibiotic, PTK 0796, a first-in-class aminomethylcycline (AMC) in Phase 3 clinical trials.
meeting with healthcare leaders to discuss ways to improve their financial performance and enhance the patient experience while exhibiting at the Healthcare Financial Management Association's Annual National Institute June 16-19 in Orlando, FL.
In the current issue of Psychotherapy and Psychosomatics a randomized controlled trial indicates that group therapy may affect the course of bipolar disorder. This study evaluated the effectiveness of adjunctive cognitive behavioral group therapy to prevent recurrence of episodes in 50 euthymic patients with bipolar disorder types I and II followed up for at least 12 months in an outpatient service and whose disease was in remission.
Virttu Biologics Limited, a UK biotechnology company with expertise in the field of oncolytic viruses, has announced that it has treated the first cohort of patients in its Phase I/IIa clinical study of its oncolytic virus, SEPREHVIR (HSV1716) for the treatment of malignant pleural mesothelioma.
› Verified 4 days ago
| NPI Number | 1821012311 |
| Organization Name | Wheaton Franciscan Home Health & Hospice, Llc |
| Address | 3070 N 51st St Ste 406 Milwaukee, Wisconsin, 53210 |
| Phone Number | (414)874-6100 |
News Archive
Paratek Pharmaceuticals, Inc. announced today that it has entered into an exclusive worldwide collaborative development, manufacturing and commercialization license agreement with Novartis for Paratek's lead broad-spectrum antibiotic, PTK 0796, a first-in-class aminomethylcycline (AMC) in Phase 3 clinical trials.
meeting with healthcare leaders to discuss ways to improve their financial performance and enhance the patient experience while exhibiting at the Healthcare Financial Management Association's Annual National Institute June 16-19 in Orlando, FL.
In the current issue of Psychotherapy and Psychosomatics a randomized controlled trial indicates that group therapy may affect the course of bipolar disorder. This study evaluated the effectiveness of adjunctive cognitive behavioral group therapy to prevent recurrence of episodes in 50 euthymic patients with bipolar disorder types I and II followed up for at least 12 months in an outpatient service and whose disease was in remission.
Virttu Biologics Limited, a UK biotechnology company with expertise in the field of oncolytic viruses, has announced that it has treated the first cohort of patients in its Phase I/IIa clinical study of its oncolytic virus, SEPREHVIR (HSV1716) for the treatment of malignant pleural mesothelioma.
› Verified 4 days ago
| Quality Measure | Provider Score | National Score |
|---|---|---|
| Patients or caregivers who were asked about treatment preferences like hospitalization and resuscitation at the beginning of hospice care | 99.9 | 98.3 |
| Patients or caregivers who were asked about their beliefs and values at the beginning of hospice care | 98.6 | 93.6 |
| Patients who were checked for pain at the beginning of hospice care | 88.2 | 93.9 |
| Patients who got a timely and thorough pain assessment when pain was identified as a problem | 78.0 | 77.7 |
| Patients who were checked for shortness of breath at the beginning of hospice care | 99.6 | 97.3 |
| Patients who got timely treatment for shortness of breath | 99.4 | 94.6 |
| Patients taking opioid pain medication who were offered care for constipation | 83.8 | 93.3 |
News Archive
Paratek Pharmaceuticals, Inc. announced today that it has entered into an exclusive worldwide collaborative development, manufacturing and commercialization license agreement with Novartis for Paratek's lead broad-spectrum antibiotic, PTK 0796, a first-in-class aminomethylcycline (AMC) in Phase 3 clinical trials.
meeting with healthcare leaders to discuss ways to improve their financial performance and enhance the patient experience while exhibiting at the Healthcare Financial Management Association's Annual National Institute June 16-19 in Orlando, FL.
In the current issue of Psychotherapy and Psychosomatics a randomized controlled trial indicates that group therapy may affect the course of bipolar disorder. This study evaluated the effectiveness of adjunctive cognitive behavioral group therapy to prevent recurrence of episodes in 50 euthymic patients with bipolar disorder types I and II followed up for at least 12 months in an outpatient service and whose disease was in remission.
Virttu Biologics Limited, a UK biotechnology company with expertise in the field of oncolytic viruses, has announced that it has treated the first cohort of patients in its Phase I/IIa clinical study of its oncolytic virus, SEPREHVIR (HSV1716) for the treatment of malignant pleural mesothelioma.
› Verified 4 days ago
| Home Health Aides | 4 |
| Counselors | 1.4 |
| Homemakers | 0.2 |
| Licensed Practical or Vocational Nurses | 1 |
| Medical Social Workers | 2 |
| Physicians | 1 |
| Registered Nurses | 12 |
| Other Personnel | 1 |
| Total Employees | 22.6 |
|---|
News Archive
Paratek Pharmaceuticals, Inc. announced today that it has entered into an exclusive worldwide collaborative development, manufacturing and commercialization license agreement with Novartis for Paratek's lead broad-spectrum antibiotic, PTK 0796, a first-in-class aminomethylcycline (AMC) in Phase 3 clinical trials.
meeting with healthcare leaders to discuss ways to improve their financial performance and enhance the patient experience while exhibiting at the Healthcare Financial Management Association's Annual National Institute June 16-19 in Orlando, FL.
In the current issue of Psychotherapy and Psychosomatics a randomized controlled trial indicates that group therapy may affect the course of bipolar disorder. This study evaluated the effectiveness of adjunctive cognitive behavioral group therapy to prevent recurrence of episodes in 50 euthymic patients with bipolar disorder types I and II followed up for at least 12 months in an outpatient service and whose disease was in remission.
Virttu Biologics Limited, a UK biotechnology company with expertise in the field of oncolytic viruses, has announced that it has treated the first cohort of patients in its Phase I/IIa clinical study of its oncolytic virus, SEPREHVIR (HSV1716) for the treatment of malignant pleural mesothelioma.
› Verified 4 days ago
| Horizon Homecare And Hospice Location: 11400 W Lake Park Drive, Milwaukee, Wisconsin, 53224 Phone: (414) 874-6170 |
| Wheaton Franciscan Hospice Location: 3070 N 51st St Suite 406, Milwaukee, Wisconsin, 53210 Phone: (414) 874-6170 |
| Heartland Hhc And Hospice Location: 1233 N Mayfair Rd Suite 100, Milwaukee, Wisconsin, 53226 Phone: (414) 874-6170 |
| Luther Manor Hospice Location: 4545 N 92nd St, Milwaukee, Wisconsin, 53225 Phone: (414) 874-6170 |